Tuesday, November 18, 2025
Behance Facebook Instagram Linkedin Twitter Vimeo VKontakte Youtube
Home 2024 February

Monthly Archives: February 2024

2024 Watch List

U.S. Population Classified as ‘Immunocompromised’ Explodes Higher, in Latest JAMA Report.

Editor / Curator -
All News

Adial Pharma (ADIL). Why Quit Drinking When You Can Just Cut...

Editor / Curator -
2024 Watch List

Interviews With Dr. Don Diamond, Lead Developer in the GeoVax (GOVX)...

Editor / Curator -
2024 Watch List

Geovax (GOVX) – City of Hope Covid Vaccine for Chronic Lymphocytic...

Editor / Curator -
2024 Watch List

The Extraordinary Dr. Koffman, Who Beat Leukemia.

Editor / Curator -
2024 Watch List

GeoVax (GOVX) Conference Call at 4:30 ET, the 29th.

Editor / Curator -
All News

Vaxart (VXRT) Gains $171 Million in Market Value After $9.2 Million...

Editor / Curator -
All News

GeoVax to Present at the 2024 BIO CEO & Investor Conference

Editor / Curator -
2024 Watch List

GeoVax Reports Positive Interim Data From Phase 2 Clinical Trial!

Editor / Curator -
2024 Watch List

GeoVax Labs (GOVX) JP Morgan 2024 Healthcare Conference Transcript.

Editor / Curator -
12Page 1 of 2

Latest article

Churchill Capital (CCCX) Infleqtion Merger.

AI Artificial Intelligence Editor / Curator -
Interview with Quantum Computing - Infleqtion CEO Matt Kinsella “I personally believe quantum is going to be a very important technological shift for humanity over...

Get Ready: Gold Crash To $3,500, Bitcoin To Collapse 90% | Mike McGlone

All News Editor / Curator -
https://youtu.be/ckZBaOOU2HM?si=ombBsU0caFKlRkEb

AI Powered Cyber Criminals Are Here. Are You Prepared?

AI Artificial Intelligence Editor / Curator -
15 Page Report on Sekur Private Data (SWISF) We've think we've come up with a way to make some money, and protect ourselves from AI...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: roland@institutionalanalyst.com
© Managed by Revelers.IO Media Group Inc.